Current and future therapeutical approaches for COVID-19

被引：15
|
作者：
Duan, Yongtao [1 ]
Yao, Yongfang [2 ]
Kumar, Senthil Arun [3 ]
Zhu, Hai-Liang [1 ,4 ]
Chang, Junbiao [2 ]
机构：
[1] Zhengzhou Univ, Henan Prov Key Lab Childrens Genet & Metab Dis, Childrens Hosp, Zhengzhou 450001, Peoples R China
[2] Zhengzhou Univ, Sch Pharmaceut Sci, Zhengzhou 450001, Henan, Peoples R China
[3] Zhengzhou Univ, Dept Endocrinol & Metab, Genet, Childrens Hosp, Zhengzhou 450001, Peoples R China
[4] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Nanjing 210093, Peoples R China
来源：
DRUG DISCOVERY TODAY | 2020年 / 25卷 / 08期
基金：
中国国家自然科学基金;
关键词：
DRUG DISCOVERY; SARS; PNEUMONIA; PLASMA; ARBIDOL;
D O I：
10.1016/j.drudis.2020.06.018
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Coronavirus 2019 (COVID-19), the WHO-classified novel coronavirus of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has rapidly become a global pandemic. To tackle both its spread and virulence, research is ongoing worldwide to develop an effective anti-COVID-19 drug or vaccine. In this review, we explore the clinical understanding and severity of COVID-19 emergence across the world, with a focus on China. We also discuss potential therapeutic targets, either host virus based, that could be used to tackle the COVID-19 outbreak.
引用
收藏
页码：1545 / 1552
页数：8
相关论文
共 50 条
  • [21] COVID-19 in children: current data and future perspectives
    Hossny, Elham
    El-Owaidy, Rasha
    EGYPTIAN JOURNAL OF PEDIATRIC ALLERGY AND IMMUNOLOGY, 2020, 18 (01): : 3 - 9
  • [22] COVID-19: Current status, Challenges and Future Perspectives
    Rajendra Prasad
    Indian Journal of Clinical Biochemistry, 2020, 35 : 383 - 384
  • [23] Current regulatory approaches for accessing potential COVID-19 therapies
    Vesa Halimi
    Armond Daci
    Simona Stojanovska
    Irina Panovska-Stavridis
    Milena Stevanovic
    Venko Filipce
    Aleksandra Grozdanova
    Journal of Pharmaceutical Policy and Practice, 13
  • [24] Pharmaceutical approaches for COVID-19: An update on current therapeutic opportunities
    Fan, Sijia
    Wang, Hongling
    Wu, Dean
    Liu, Lu
    ACTA PHARMACEUTICA, 2023, 73 (02) : 157 - 173
  • [25] Current Approaches to COVID-19 Drug Discovery and Safety Assessment
    Williams, David E.
    Kankanamge, Lakindu S. Pathira
    CHEMICAL RESEARCH IN TOXICOLOGY, 2022, 35 (12) : 2183 - 2185
  • [26] Current regulatory approaches for accessing potential COVID-19 therapies
    Halimi, Vesa
    Daci, Armond
    Stojanovska, Simona
    Panovska-Stavridis, Irina
    Stevanovic, Milena
    Filipce, Venko
    Grozdanova, Aleksandra
    JOURNAL OF PHARMACEUTICAL POLICY AND PRACTICE, 2020, 13 (01)
  • [27] The Future of COVID-19
    Hussaini, Najia
    Varon, Joseph
    CURRENT RESPIRATORY MEDICINE REVIEWS, 2021, 17 (04) : 199 - 200
  • [28] COVID-19 and the Future
    Wang, Jeffrey C.
    Wiechert, Karsten
    Chapman, Jens R.
    GLOBAL SPINE JOURNAL, 2021, 11 (04) : 429 - 429
  • [29] Detection of COVID-19: A review of the current literature and future perspectives
    Ji, Tianxing
    Liu, Zhenwei
    Wang, GuoQiang
    Guo, Xuguang
    Khan, Shahzad Akbar
    Lai, Changchun
    Chen, Haoyu
    Huang, Shiwen
    Xia, Shaomei
    Chen, Bo
    Jia, Hongyun
    Chen, Yangchao
    Zhou, Qiang
    BIOSENSORS & BIOELECTRONICS, 2020, 166
  • [30] Otolaryngology Education in the Setting of COVID-19: Current and Future Implications
    Comer, Brett T. Z.
    Gupta, Nikita
    Mowry, Sarah E.
    Malekzadeh, Sonya
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2020, 163 (01) : 70 - 74
12345